======= KRTCAP2 ======= == Gene Information == * **Official Symbol**: KRTCAP2 * **Official Name**: keratinocyte associated protein 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=200185|200185]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N6L1|Q8N6L1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KRTCAP2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KRTCAP2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619029|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as accessory component of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains. Required for efficient substrate- specific N-glycosylation probably involving the STT3A-containing OST complex. May be involved in N-glycosylation of APP (amyloid- beta precursor protein). Can modulate gamma-secretase cleavage of APP by enhancing endoprotelysis of PSEN1. {ECO:0000269|PubMed:21768116, ECO:0000269|PubMed:22467853, ECO:0000305}. |Keratin assoc| |protein N-linked glycosylation via arginine| |oligosaccharyltransferase complex| |peptidyl-arginine modification| |protein N-linked glycosylation| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |cellular component| |carbohydrate derivative biosynthetic process| |molecular function| |peptidyl-amino acid modification| |carbohydrate derivative metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|-1.85| |[[:results:exp183|IU1-C 25μM R04 exp183]]|-1.75| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-1.73| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.85| |[[:results:exp235|Geldanamycin 0.01μM R05 exp235]]|1.87| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.98| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15808 * **Expression level (log2 read counts)**: 5.27 {{:chemogenomics:nalm6 dist.png?nolink |}}